Grifols, S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GIKLY research report →
About the company
Grifols, S. A. is a company dedicated to the acquisition, production, processing, and distribution of therapeutic goods, with a primary focus on plasma-derived medicines.
- CEO
- Jose Ignacio Abia Buenache
- IPO
- 2010
- Employees
- 23,833
- HQ
- Barcelona, ES
Price Chart
- Market Cap
- $13.40B
- P/E
- 14.78
- P/S
- 0.83
- P/B
- 1.12
- EV/EBITDA
- 10.54
- Div Yield
- 0.91%
- Gross Margin
- 37.68%
- Op Margin
- 16.89%
- Net Margin
- 5.58%
- ROE
- 7.88%
- ROIC
- 5.49%
- Revenue
- $7.52B · 4.32%
- Net Income
- $386.03M · 146.00%
- EPS
- $0.28 · 143.48%
- Op Income
- $1.25B
- FCF YoY
- 41.51%
- 52W High
- $7.49
- 52W Low
- $4.77
- 50D MA
- $5.39
- 200D MA
- $6.06
- Beta
- 1.18
- Avg Volume
- 287
Get TickerSpark's AI analysis on GIKLY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GIKLY coverage
Recent articles, reports, and earnings notes.
No research on GIKLY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GIKLY report →Similar companies
Peers in the same neighborhood.